Akorn, Inc. is recalling 10,543 tubes of Lidocaine Hydrochloride Jelly USP, 2% (generic lidocaine), a sterile local anesthetic. The recall was initiated after metal particles were found on the filling line equipment during production, suggesting a risk that the medication could be contaminated. While no metal has been found inside the actual product tubes to date, this voluntary recall affects 30 mL tubes distributed nationwide and in Puerto Rico. Consumers should check their medicine cabinets for this specific product, particularly those from the affected lot number 9B21A.
Although no metal particles were detected within the product itself, the presence of metal debris on the filling line indicates a potential for foreign material to enter the sterile jelly. If contaminated product is used, it could cause irritation, injury, or localized infection at the site of application.
Healthcare consultation and product refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.